The results of this study provide new dimension to our understanding of the complexity of the processes underlying PCa progression and not only support the view on TRPM8 as a potential molecular target in anti-PCa therapy9,24, but also highlight the AR as a TRPM8 regulator protein that should be taken into the account upon development of novel anti-PCa therapeutic strategies. This evidence concerns the gene AR and posterior cortical atrophy.